博安生物股东将股票由中信证券经纪香港转入香港上海汇丰银行 转仓市值8.48亿港元

Group 1 - The core point of the article highlights that on February 2, Boan Biotechnology (06955) shareholders transferred stocks from CITIC Securities Brokerage Hong Kong to HSBC Hong Kong, with a transfer market value of HKD 848 million, accounting for 16.37% of the total [1] - Boan Biotechnology's board has been informed by its controlling shareholder, Green Leaf Pharmaceutical Group, regarding a proposed transfer of 11.9866 million H-shares by its wholly-owned subsidiary, Shandong Green Leaf Pharmaceutical Co., Ltd., to be executed in the market by January 27, 2026, as per the terms of the subscription agreement related to the exchangeable preferred shares [1]